- Medical news articles blogs and discussions Home » Upcoming News » Paediatrics
-
Sort Paediatrics by:
Newest |
Oldest |
Most Popular |
Least Popular |
The TRIGR study is the first study ever aimed at primary prevention of type 1 diabetes. The study is designed to answer to the question whether excluding cow's milk protein from the infant's diet decreases the risk of future diabetes.
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Findings of a cot death study that helped to discredit the paediatrician Professor Sir Roy Meadow were challenged by a report published yesterday in the British Medical Journal.
read more »
Source:http://news.independent.co.uk
Discuss Bury
Source:http://news.independent.co.uk
Discuss Bury
Conclusions Prophylaxis with isoniazid has an early survival benefit and reduces incidence of tuberculosis in children with HIV. Prophylaxis may offer an effective public health intervention to reduce mortality in such children in settings with a high prevalence of tuberculosis.
read more »
Source:http://www.bmj.com
Discuss Bury
Source:http://www.bmj.com
Discuss Bury
Third Wave Technologies Inc. (Nasdaq: TWTI) today announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its InPlex(TM) Cystic Fibrosis Molecular Test. [click link for full article]
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Dublin, Ireland and Cambridge, MA - December 15, 2006 - Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval to market TYSABRIŽ (natalizum...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
A new, large survey supported by the Crohn's & Colitis Foundation of America (CCFA) finds that 65 percent of ulcerative colitis (UC) patients are less than fully compliant with first-line therapies to treat their disease. The findings are significant because an earlier study found that patients less...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
A recent University of Iowa study reveals a new immune defense mechanism in normal airways and may help explain why people with cystic fibrosis (CF) are particularly susceptible to bacterial lung infections. The findings also may point the way to new approaches for treating the disease.The UI study ...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
PARI Aerosol Research Institute and The Hospital for Sick Children (SickKids) in Toronto are studying an inhaled L-arginine formulation delivered by PARI's eFlow to treat cystic fibrosis. Dr. Felix Ratjen, chief of Respiratory Medicine and senior scientist in Physiology & Experimental Medicine a...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Crohn disease (CD) and ulcerative colitis (UC) are the two most common inflammatory bowel diseases. Both are caused by chronic inflammation in the intestine, although the types of inflammation underlying these disorders differ -- CD is characterized by a Th1 inflammatory response and UC by a Th2 inf...
read more »
Source:http://www.medicalnewstoday.com
Discuss Bury
Source:http://www.medicalnewstoday.com
Discuss Bury
Medinews is an online community dedicated for promoting and discussing latest medical news, research articles and blogs. You can also find regular updates on health news for discussion by health professionals.
